Literature DB >> 1268179

Scleritis and episcleritis.

P G Watson, S S Hayreh.   

Abstract

The data from 159 patients (217 eyes) with episscleritis and 207 patients (301 eyes) with scleritis have been investigated in detail and the results analysed with the help of a computer. Of these patients, 91 per cent were followed-up during a period of one to eight years. A new classification is presented which is as follows: Episcleritis (217 eyes) Simple episcleritis (170 eyes) Nodular episcleritis (47 eyes) Scleritis (301 eyes) Diffuse anterior scleritis (119 eyes) Nodular anterior scleritis (134 eyes) Necrotizing scleritis (42 eyes). Of these, 13 were regarded as scleromalacia perforans. Posterior scleritis (6 eyes) The diagnosis is based on an exact clinical examination which is fully described. Episcleritis has been shown to be a benign recurring condition, a mild keratitis being the only occasional complication. Episcleritis does not progress to scleritis, except in the case of herpes zoster which sometimes starts as an episcleritis with the vesicular stage of the eruption, to reappear three months later as a scleritis in the same site. No clear conclusions could be drawn as to the aetiology of episcleritis.

Entities:  

Mesh:

Year:  1976        PMID: 1268179      PMCID: PMC1042706          DOI: 10.1136/bjo.60.3.163

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  Effect of cortisone on rheumatoid nodules of the sclera (scleromalacia perforans).

Authors:  N ASHTON; H E HOBBS
Journal:  Br J Ophthalmol       Date:  1952-07       Impact factor: 4.638

2.  Treatment of episcleritis. A double-blind trial comparing betamethasone 0.1 per cent, oxyphenbutazone 10 per cent, and placebo eye ointments.

Authors:  P G Watson; D A McKay; R S Clemett; P Wilkinson
Journal:  Br J Ophthalmol       Date:  1973-11       Impact factor: 4.638

3.  [Scleroplasties in anterior segment diseases, using homografts after vacuum preservation in the presence of calcium chloride].

Authors:  P Vancea; P P Vancea; L Jalobceastîi; G Colve; A Călin
Journal:  Arch Ophtalmol Rev Gen Ophtalmol       Date:  1971-10

4.  Incidence of eye disease in cases of connective tissue disease.

Authors:  J Williamson
Journal:  Trans Ophthalmol Soc U K       Date:  1974-09

5.  Anterior segment changes in connective tissue disease.

Authors:  P G Watson
Journal:  Trans Ophthalmol Soc U K       Date:  1974-09

6.  Rheumatic disease in patients suffering from scleral disease.

Authors:  P Fowler
Journal:  Ann Rheum Dis       Date:  1970-03       Impact factor: 19.103

7.  Double-blind trial of the treatment of episcleritis-scleritis with oxyphenbutazone or prednisolone.

Authors:  P G Watson; D J Lobascher; D W Sabiston; E Lewis-Faning; P D Fowler; B R Jones
Journal:  Br J Ophthalmol       Date:  1966-08       Impact factor: 4.638

8.  Fascia lata grafting in scleromalacia perforans with lamellar corneal-scleral dissection.

Authors:  R T Torchia; R E Dunn; P J Pease
Journal:  Am J Ophthalmol       Date:  1968-10       Impact factor: 5.258

9.  Necrogranulomatous scleritis. Clinical and histologic features.

Authors:  D Sevel
Journal:  Am J Ophthalmol       Date:  1967-12       Impact factor: 5.258

10.  Evaluation of eyes enucleated for scleritis.

Authors:  F T Fraunfelder; P G Watson
Journal:  Br J Ophthalmol       Date:  1976-03       Impact factor: 4.638

View more
  93 in total

1.  Ocular sarcoidosis.

Authors:  Maria do Socorro Costa da Silva; Leonardo Rodrigues Campos
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

Review 2.  [Intrascleral haptic fixation of intraocular lenses].

Authors:  G B Scharioth
Journal:  Ophthalmologe       Date:  2014-03       Impact factor: 1.059

Review 3.  Biologic therapy for refractory scleritis: a new treatment perspective.

Authors:  Tania Sales de Alencar de Fidelix; Luis Antonio Vieira; Denise de Freitas; Virginia Fernandes Moça Trevisani
Journal:  Int Ophthalmol       Date:  2015-08-29       Impact factor: 2.031

4.  Ophthaproblem.

Authors:  Khalid Hasanee; Sanjay Sharma
Journal:  Can Fam Physician       Date:  2003-08       Impact factor: 3.275

5.  Clinical characteristics and ocular complications of patients with scleritis in Japanese.

Authors:  Rie Tanaka; Toshikatsu Kaburaki; Kazuyoshi Ohtomo; Mitsuko Takamoto; Keiko Komae; Jiro Numaga; Yujiro Fujino; Makoto Aihara
Journal:  Jpn J Ophthalmol       Date:  2018-05-23       Impact factor: 2.447

6.  Orbital myositis in scleritis.

Authors:  Z F H M Boonman; R J W De Keizer; H S Graniewski-Wijnands; P G Watson
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

7.  Ulceration of the cornea in rheumatoid arthritis.

Authors:  M I Jayson; D L Easty
Journal:  Ann Rheum Dis       Date:  1977-10       Impact factor: 19.103

8.  Complications of misdiagnosed and inadequately treated necrotizing scleritis studied by ultrasound biomicroscopy and computerized corneal topography.

Authors:  D Meller; T Böker
Journal:  Int Ophthalmol       Date:  1997       Impact factor: 2.031

Review 9.  Ocular inflammatory diseases associated with rheumatoid arthritis.

Authors:  Mathieu Artifoni; Pierre-Raphaël Rothschild; Antoine Brézin; Loïc Guillevin; Xavier Puéchal
Journal:  Nat Rev Rheumatol       Date:  2013-12-10       Impact factor: 20.543

10.  High expression of interleukin-1beta in the corneal epithelium of MRL/lpr mice is under the control of their genetic background.

Authors:  M Okamoto; M Takagi; M Kutsuna; Y Hara; M Nishihara; M C Zhang; T Matsuda; M Sakanaka; S Okamoto; M Nose; Y Ohashi
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.